25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

0JW9 (MEI Pharma Inc.) Stock Analysis
Buy, Hold or Sell?

Let's analyze MEI Pharma Inc. together

I guess you are interested in MEI Pharma Inc.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – MEI Pharma Inc.’s Financial Insights
  • 📈 Technical Analysis (TA) – MEI Pharma Inc.’s Price Targets

I'm going to help you getting a better view of MEI Pharma Inc.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about MEI Pharma Inc.

I send you an email if I find something interesting about MEI Pharma Inc..

1. Quick Overview

1.1. Quick analysis of MEI Pharma Inc. (30 sec.)










1.2. What can you expect buying and holding a share of MEI Pharma Inc.? (30 sec.)

How much money do you get?

How much money do you get?
$0.16
When do you have the money?
1 year
How often do you get paid?
7.5%

What is your share worth?

Current worth
$0.31
Expected worth in 1 year
$-0.22
How sure are you?
32.5%

+ What do you gain per year?

Total Gains per Share
$-0.36
Return On Investment
-18.5%

For what price can you sell your share?

Current Price per Share
$1.96
Expected price per share
$1.7974 - $2.305
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of MEI Pharma Inc. (5 min.)




Live pricePrice per Share (EOD)
$1.96
Intrinsic Value Per Share
$-4.77 - $0.91
Total Value Per Share
$-4.46 - $1.23

2.2. Growth of MEI Pharma Inc. (5 min.)




Is MEI Pharma Inc. growing?

Current yearPrevious yearGrowGrow %
How rich?$22m$49.9m-$17.2m-52.5%

How much money is MEI Pharma Inc. making?

Current yearPrevious yearGrowGrow %
Making money-$9.5m$4.9m-$14.5m-151.9%
Net Profit Margin0.0%-216.0%--

How much money comes from the company's main activities?

2.3. Financial Health of MEI Pharma Inc. (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of MEI Pharma Inc.?

Welcome investor! MEI Pharma Inc.'s management wants to use your money to grow the business. In return you get a share of MEI Pharma Inc..

First you should know what it really means to hold a share of MEI Pharma Inc.. And how you can make/lose money.

Speculation

The Price per Share of MEI Pharma Inc. is $1.9571. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of MEI Pharma Inc..
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in MEI Pharma Inc., you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.31. Based on the TTM, the Book Value Change Per Share is $-0.13 per quarter. Based on the YOY, the Book Value Change Per Share is $0.04 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.04 per quarter.
Based on historical numbers we can estimate the returns while holding a share of MEI Pharma Inc..

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.04-1.9%-0.13-6.9%0.094.5%-0.05-2.6%-0.11-5.4%-0.09-4.7%
Usd Book Value Change Per Share-0.04-2.0%-0.13-6.7%0.042.0%-0.06-3.3%-0.04-2.0%-0.02-0.9%
Usd Dividend Per Share0.000.0%0.042.1%0.042.1%0.031.4%0.020.8%0.010.4%
Usd Total Gains Per Share-0.04-2.0%-0.09-4.6%0.084.1%-0.04-1.9%-0.02-1.1%-0.01-0.5%
Usd Price Per Share2.46-2.98-5.07-2.84-2.44-1.35-
Price to Earnings Ratio-16.33--8.19--4.76--4.48--3.68--2.08-
Price-to-Total Gains Ratio-62.89--3.98--20.08--8.67--12.69--13.58-
Price to Book Ratio7.91-6.87-8.29-5.27-4.28-2.40-
Price-to-Total Gains Ratio-62.89--3.98--20.08--8.67--12.69--13.58-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.9571
Number of shares510
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.040.02
Usd Book Value Change Per Share-0.13-0.04
Usd Total Gains Per Share-0.09-0.02
Gains per Quarter (510 shares)-46.12-11.40
Gains per Year (510 shares)-184.50-45.61
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
184-268-19434-79-56
2167-536-37867-158-102
3251-804-562101-237-148
4334-1072-746134-317-194
5418-1341-930168-396-240
6502-1609-1114201-475-286
7585-1877-1298235-554-332
8669-2145-1482268-633-378
9752-2413-1666302-712-424
10836-2681-1850335-791-470

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%2.010.00.016.7%2.018.00.010.0%5.035.00.012.5%5.085.00.05.6%
Book Value Change Per Share0.04.00.00.0%2.010.00.016.7%5.015.00.025.0%12.028.00.030.0%24.061.05.026.7%
Dividend per Share1.00.03.025.0%3.00.09.025.0%3.00.017.015.0%3.00.037.07.5%5.00.085.05.6%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%6.014.00.030.0%13.027.00.032.5%25.060.05.027.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of MEI Pharma Inc. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.039-0.131+236%0.039-200%-0.065+65%-0.039-1%-0.018-54%
Book Value Per Share--0.3110.461-33%0.702-56%0.629-51%0.732-58%0.715-57%
Current Ratio--10.6627.844+36%7.236+47%7.255+47%6.993+52%9.078+17%
Debt To Asset Ratio--0.0940.171-45%0.495-81%0.455-79%0.527-82%0.375-75%
Debt To Equity Ratio--0.1030.217-52%1.844-94%1.495-93%1.795-94%1.089-91%
Dividend Per Share---0.041-100%0.041-100%0.027-100%0.016-100%0.008-100%
Enterprise Value--196278233.200240043164.665-18%390470806.135-50%230251079.997-15%233040990.673-16%231672655.023-15%
Eps---0.038-0.134+257%0.089-142%-0.052+37%-0.105+180%-0.092+145%
Ev To Ebitda Ratio---14.219-9.085-36%-4.899-66%-4.786-66%-4.483-68%-4.680-67%
Free Cash Flow Per Share---0.052-0.127+146%-0.186+261%-0.177+243%-0.100+94%-0.087+68%
Free Cash Flow To Equity Per Share---0.052-0.127+147%-0.227+341%-0.190+269%-0.057+10%-0.019-62%
Gross Profit Margin--1.0001.006-1%1.068-6%1.033-3%1.020-2%1.010-1%
Intrinsic Value_10Y_max--0.915----------
Intrinsic Value_10Y_min---4.773----------
Intrinsic Value_1Y_max---0.284----------
Intrinsic Value_1Y_min---0.673----------
Intrinsic Value_3Y_max---0.566----------
Intrinsic Value_3Y_min---1.865----------
Intrinsic Value_5Y_max---0.504----------
Intrinsic Value_5Y_min---2.876----------
Market Cap139199520.340-26%174826233.200212094164.665-18%360607556.135-52%202039996.663-13%173736592.072+1%96221286.136+82%
Net Profit Margin----0%-2.1600%-1.0450%-1.5440%-3.7350%
Operating Margin----0%-2.2260%-1.0880%-1.9070%-3.7010%
Operating Ratio----0%3.236-100%1.875-100%2.913-100%4.554-100%
Pb Ratio6.299-26%7.9116.872+15%8.290-5%5.272+50%4.276+85%2.400+230%
Pe Ratio-13.000+20%-16.327-8.192-50%-4.762-71%-4.480-73%-3.675-77%-2.078-87%
Price Per Share1.957-26%2.4582.982-18%5.070-52%2.841-13%2.443+1%1.353+82%
Price To Free Cash Flow Ratio-9.493+20%-11.922-10.493-12%-6.860-42%-5.961-50%-4.032-66%-2.291-81%
Price To Total Gains Ratio-50.072+20%-62.887-3.984-94%-20.084-68%-8.675-86%-12.687-80%-13.576-78%
Quick Ratio--10.38011.737-12%12.835-19%12.237-15%12.130-14%15.897-35%
Return On Assets---0.110-0.243+121%0.054-302%-0.077-30%-0.072-34%-0.077-30%
Return On Equity---0.121-0.295+143%-0.087-28%-0.183+51%-0.204+69%-0.163+35%
Total Gains Per Share---0.039-0.090+131%0.080-149%-0.037-5%-0.022-43%-0.010-75%
Usd Book Value--22098000.00032756250.000-33%49956750.000-56%44729416.667-51%52034800.000-58%50836175.000-57%
Usd Book Value Change Per Share---0.039-0.131+236%0.039-200%-0.065+65%-0.039-1%-0.018-54%
Usd Book Value Per Share--0.3110.461-33%0.702-56%0.629-51%0.732-58%0.715-57%
Usd Dividend Per Share---0.041-100%0.041-100%0.027-100%0.016-100%0.008-100%
Usd Enterprise Value--196278233.200240043164.665-18%390470806.135-50%230251079.997-15%233040990.673-16%231672655.023-15%
Usd Eps---0.038-0.134+257%0.089-142%-0.052+37%-0.105+180%-0.092+145%
Usd Free Cash Flow---3666000.000-9010750.000+146%-13235750.000+261%-12576416.667+243%-7100350.000+94%-6166300.000+68%
Usd Free Cash Flow Per Share---0.052-0.127+146%-0.186+261%-0.177+243%-0.100+94%-0.087+68%
Usd Free Cash Flow To Equity Per Share---0.052-0.127+147%-0.227+341%-0.190+269%-0.057+10%-0.019-62%
Usd Market Cap139199520.340-26%174826233.200212094164.665-18%360607556.135-52%202039996.663-13%173736592.072+1%96221286.136+82%
Usd Price Per Share1.957-26%2.4582.982-18%5.070-52%2.841-13%2.443+1%1.353+82%
Usd Profit---2677000.000-9555000.000+257%4960000.000-154%-4128666.667+54%-7224700.000+170%-6434475.000+140%
Usd Revenue----0%18162000.000-100%11268416.667-100%10955650.000-100%6274250.000-100%
Usd Total Gains Per Share---0.039-0.090+131%0.080-149%-0.037-5%-0.022-43%-0.010-75%
 EOD+3 -5MRQTTM+20 -15YOY+13 -243Y+18 -195Y+18 -1910Y+16 -21

3.3 Fundamental Score

Let's check the fundamental score of MEI Pharma Inc. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-13.000
Price to Book Ratio (EOD)Between0-16.299
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than110.380
Current Ratio (MRQ)Greater than110.662
Debt to Asset Ratio (MRQ)Less than10.094
Debt to Equity Ratio (MRQ)Less than10.103
Return on Equity (MRQ)Greater than0.15-0.121
Return on Assets (MRQ)Greater than0.05-0.110
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of MEI Pharma Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.707
Ma 20Greater thanMa 501.944
Ma 50Greater thanMa 1002.291
Ma 100Greater thanMa 2002.467
OpenGreater thanClose2.109
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About MEI Pharma Inc.

MEI Pharma, Inc., a clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer. It develops ME-344, an intravenous small molecule inhibitor mitochondrial oxidative phosphorylation to treat human epidermal growth factor receptor 2 negative breast cancer, colorectal cancer, and solid tumors. The company was formerly known as Marshall Edwards, Inc. and changed its name to MEI Pharma, Inc. in July 2012. MEI Pharma, Inc. was incorporated in 2000 and is headquartered in San Diego, California.

Fundamental data was last updated by Penke on 2025-04-17 00:09:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit MEI Pharma Inc. earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare MEI Pharma Inc. to the  industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of MEI Pharma Inc.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-216.0%+216.0%
TTM-5Y-154.4%+154.4%
5Y-154.4%10Y-373.5%+219.1%
4.3.1.2. Return on Assets

Shows how efficient MEI Pharma Inc. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare MEI Pharma Inc. to the  industry mean.
  • -11.0% Return on Assets means that MEI Pharma Inc. generated $-0.11 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of MEI Pharma Inc.:

  • The MRQ is -11.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -24.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-11.0%TTM-24.3%+13.3%
TTM-24.3%YOY5.4%-29.7%
TTM-24.3%5Y-7.2%-17.1%
5Y-7.2%10Y-7.7%+0.5%
4.3.1.3. Return on Equity

Shows how efficient MEI Pharma Inc. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare MEI Pharma Inc. to the  industry mean.
  • -12.1% Return on Equity means MEI Pharma Inc. generated $-0.12 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of MEI Pharma Inc.:

  • The MRQ is -12.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -29.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.1%TTM-29.5%+17.4%
TTM-29.5%YOY-8.7%-20.7%
TTM-29.5%5Y-20.4%-9.0%
5Y-20.4%10Y-16.3%-4.1%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of MEI Pharma Inc..

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient MEI Pharma Inc. is operating .

  • Measures how much profit MEI Pharma Inc. makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare MEI Pharma Inc. to the  industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of MEI Pharma Inc.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-222.6%+222.6%
TTM-5Y-190.7%+190.7%
5Y-190.7%10Y-370.1%+179.4%
4.3.2.2. Operating Ratio

Measures how efficient MEI Pharma Inc. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of MEI Pharma Inc.:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY3.236-3.236
TTM-5Y2.913-2.913
5Y2.91310Y4.554-1.641
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of MEI Pharma Inc..

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if MEI Pharma Inc. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 10.66 means the company has $10.66 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of MEI Pharma Inc.:

  • The MRQ is 10.662. The company is very able to pay all its short-term debts. +2
  • The TTM is 7.844. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ10.662TTM7.844+2.818
TTM7.844YOY7.236+0.608
TTM7.8445Y6.993+0.851
5Y6.99310Y9.078-2.086
4.4.3.2. Quick Ratio

Measures if MEI Pharma Inc. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare MEI Pharma Inc. to the  industry mean.
  • A Quick Ratio of 10.38 means the company can pay off $10.38 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of MEI Pharma Inc.:

  • The MRQ is 10.380. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 11.737. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ10.380TTM11.737-1.357
TTM11.737YOY12.835-1.098
TTM11.7375Y12.130-0.394
5Y12.13010Y15.897-3.766
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of MEI Pharma Inc..

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of MEI Pharma Inc. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare MEI Pharma Inc. to industry mean.
  • A Debt to Asset Ratio of 0.09 means that MEI Pharma Inc. assets are financed with 9.4% credit (debt) and the remaining percentage (100% - 9.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of MEI Pharma Inc.:

  • The MRQ is 0.094. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.171. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.094TTM0.171-0.077
TTM0.171YOY0.495-0.324
TTM0.1715Y0.527-0.356
5Y0.52710Y0.375+0.152
4.5.4.2. Debt to Equity Ratio

Measures if MEI Pharma Inc. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare MEI Pharma Inc. to the  industry mean.
  • A Debt to Equity ratio of 10.3% means that company has $0.10 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of MEI Pharma Inc.:

  • The MRQ is 0.103. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.217. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.103TTM0.217-0.114
TTM0.217YOY1.844-1.627
TTM0.2175Y1.795-1.578
5Y1.79510Y1.089+0.705
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings MEI Pharma Inc. generates.

  • Above 15 is considered overpriced but always compare MEI Pharma Inc. to the  industry mean.
  • A PE ratio of -16.33 means the investor is paying $-16.33 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of MEI Pharma Inc.:

  • The EOD is -13.000. Based on the earnings, the company is expensive. -2
  • The MRQ is -16.327. Based on the earnings, the company is expensive. -2
  • The TTM is -8.192. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-13.000MRQ-16.327+3.327
MRQ-16.327TTM-8.192-8.134
TTM-8.192YOY-4.762-3.430
TTM-8.1925Y-3.675-4.517
5Y-3.67510Y-2.078-1.597
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of MEI Pharma Inc.:

  • The EOD is -9.493. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -11.922. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -10.493. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-9.493MRQ-11.922+2.430
MRQ-11.922TTM-10.493-1.429
TTM-10.493YOY-6.860-3.634
TTM-10.4935Y-4.032-6.461
5Y-4.03210Y-2.291-1.741
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of MEI Pharma Inc. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 7.91 means the investor is paying $7.91 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of MEI Pharma Inc.:

  • The EOD is 6.299. Based on the equity, the company is overpriced. -1
  • The MRQ is 7.911. Based on the equity, the company is overpriced. -1
  • The TTM is 6.872. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD6.299MRQ7.911-1.612
MRQ7.911TTM6.872+1.039
TTM6.872YOY8.290-1.417
TTM6.8725Y4.276+2.596
5Y4.27610Y2.400+1.876
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-12-31. All numbers in thousands.

Summary
Total Assets24,385
Total Liabilities2,287
Total Stockholder Equity22,098
 As reported
Total Liabilities 2,287
Total Stockholder Equity+ 22,098
Total Assets = 24,385

Assets

Total Assets24,385
Total Current Assets24,385
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 23,739
Other Current Assets 646
Total Current Assets  (as reported)24,385
Total Current Assets  (calculated)24,385
+/-0
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,287
Long-term Liabilities0
Total Stockholder Equity22,098
Total Current Liabilities
Accounts payable 596
Other Current Liabilities 1,691
Total Current Liabilities  (as reported)2,287
Total Current Liabilities  (calculated)2,287
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Retained Earnings -398,903
Other Stockholders Equity 421,001
Total Stockholder Equity (as reported)22,098
Total Stockholder Equity (calculated)22,098
+/-0
Other
Cash and Short Term Investments 23,739
Common Stock Shares Outstanding 6,663
Liabilities and Stockholders Equity 24,385
Net Debt -23,739
Net Working Capital 22,098



6.2. Balance Sheets Structured

All numbers in thousands.

 Trend2024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-05-122010-02-092009-08-282009-06-302009-03-312009-02-042008-09-032008-06-302008-03-312008-01-222007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302001-03-31
> Total Assets 
0
0
0
0
7,286
6,567
32,368
25,560
24,849
23,836
23,126
20,501
19,364
18,582
17,785
13,324
10,395
20,958
20,299
18,352
16,290
29,031
26,633
23,198
19,978
27,020
23,306
23,306
19,356
15,287
11,451
9,136
9,136
7,618
6,065
5,211
4,168
4,943
5,222
3,293
6,373
4,355
27,584
24,947
36,547
32,617
61,155
56,043
49,808
42,917
79,738
71,598
64,750
59,068
55,016
50,931
47,164
61,045
58,210
59,891
55,704
48,031
43,567
37,397
104,657
94,750
96,305
85,926
82,663
68,923
107,105
96,623
209,728
214,009
203,880
186,122
174,098
176,351
209,464
194,429
177,840
163,583
147,599
134,187
120,809
101,251
78,538
71,260
41,375
27,750
24,385
24,38527,75041,37571,26078,538101,251120,809134,187147,599163,583177,840194,429209,464176,351174,098186,122203,880214,009209,72896,623107,10568,92382,66385,92696,30594,750104,65737,39743,56748,03155,70459,89158,21061,04547,16450,93155,01659,06864,75071,59879,73842,91749,80856,04361,15532,61736,54724,94727,5844,3556,3733,2935,2224,9434,1685,2116,0657,6189,1369,13611,45115,28719,35623,30623,30627,02019,97823,19826,63329,03116,29018,35220,29920,95810,39513,32417,78518,58219,36420,50123,12623,83624,84925,56032,3686,5677,2860000
   > Total Current Assets 
0
0
0
0
7,286
6,567
32,368
25,560
24,849
23,836
23,126
20,501
19,364
18,582
17,785
13,324
10,395
20,958
20,299
18,352
16,290
29,031
26,633
23,198
19,978
27,020
23,306
23,306
19,356
15,287
11,451
9,133
9,133
7,570
6,020
5,170
4,130
4,908
5,191
3,265
6,348
3,836
27,074
24,427
36,029
32,106
60,656
55,538
49,290
42,415
79,241
71,112
64,281
58,614
54,577
50,504
46,749
60,642
57,822
59,516
55,323
47,664
43,213
37,056
104,329
94,435
95,833
85,443
82,198
68,051
106,445
95,402
208,644
203,930
194,032
176,561
164,817
167,362
200,725
183,466
167,126
148,907
133,445
120,483
107,528
88,422
66,172
59,366
40,769
27,745
24,385
24,38527,74540,76959,36666,17288,422107,528120,483133,445148,907167,126183,466200,725167,362164,817176,561194,032203,930208,64495,402106,44568,05182,19885,44395,83394,435104,32937,05643,21347,66455,32359,51657,82260,64246,74950,50454,57758,61464,28171,11279,24142,41549,29055,53860,65632,10636,02924,42727,0743,8366,3483,2655,1914,9084,1305,1706,0207,5709,1339,13311,45115,28719,35623,30623,30627,02019,97823,19826,63329,03116,29018,35220,29920,95810,39513,32417,78518,58219,36420,50123,12623,83624,84925,56032,3686,5677,2860000
       Cash And Cash Equivalents 
0
0
0
0
7,244
6,375
32,304
25,546
24,819
23,782
23,106
20,231
9,238
8,422
17,735
12,863
10,054
20,894
20,226
18,271
16,158
28,927
26,571
22,902
19,743
26,941
23,152
23,152
19,067
15,233
11,341
9,031
9,031
7,479
5,827
4,851
3,858
4,800
4,991
2,722
6,202
3,713
26,877
24,167
35,573
31,504
39,762
19,670
13,777
17,041
23,657
20,465
18,722
17,876
13,674
14,291
10,837
13,789
15,050
11,644
8,458
6,958
7,339
6,198
13,309
6,118
8,748
7,426
9,590
5,984
8,638
7,438
12,331
10,956
9,877
9,745
8,543
15,621
12,551
11,112
15,740
14,653
10,917
8,812
16,906
3,372
5,174
2,368
3,705
6,952
23,739
23,7396,9523,7052,3685,1743,37216,9068,81210,91714,65315,74011,11212,55115,6218,5439,7459,87710,95612,3317,4388,6385,9849,5907,4268,7486,11813,3096,1987,3396,9588,45811,64415,05013,78910,83714,29113,67417,87618,72220,46523,65717,04113,77719,67039,76231,50435,57324,16726,8773,7136,2022,7224,9914,8003,8584,8515,8277,4799,0319,03111,34115,23319,06723,15223,15226,94119,74322,90226,57128,92716,15818,27120,22620,89410,05412,86317,7358,4229,23820,23123,10623,78224,81925,54632,3046,3757,2440000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
10,000
10,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,001
35,007
35,016
25,021
55,051
50,055
45,057
40,142
40,116
35,111
35,081
45,112
40,104
45,116
45,107
40,065
35,102
30,004
89,434
84,646
84,667
74,864
64,899
59,932
95,243
85,360
170,299
165,179
170,267
154,879
144,883
129,882
173,200
157,930
137,512
123,714
113,256
103,224
83,787
78,830
54,306
54,184
34,640
19,953
0
019,95334,64054,18454,30678,83083,787103,224113,256123,714137,512157,930173,200129,882144,883154,879170,267165,179170,29985,36095,24359,93264,89974,86484,66784,64689,43430,00435,10240,06545,10745,11640,10445,11235,08135,11140,11640,14245,05750,05555,05125,02135,01635,00720,0010000000000000000000000000000000010,00010,000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
394
457
530
530
5,274
795
577
586
2,941
25,916
10,606
7,432
7,582
18,120
10,151
8,446
10,044
7,758
5,704
4,580
85
0
0
0
0
0
0
000000854,5805,7047,75810,0448,44610,15118,1207,5827,43210,60625,9162,9415865777955,2745305304573940000000000000000000000000000000000000000000000000000000000000000
       Other Current Assets 
0
0
0
0
42
192
64
14
30
54
20
270
126
160
50
461
341
64
73
81
132
104
62
296
235
79
65
154
289
54
45
110
102
91
193
319
272
108
200
543
146
123
394
260
912
602
893
861
497
353
533
592
502
596
787
1,102
1,662
3,482
5,336
5,512
3,516
1,282
1,544
1,708
2,778
6,885
2,418
3,153
7,709
2,135
2,564
2,604
2,736
27,795
17,170
16,442
3,809
3,739
4,823
5,978
7,660
5,564
3,568
3,867
11,349
6,220
6,692
2,814
2,424
840
646
6468402,4242,8146,6926,22011,3493,8673,5685,5647,6605,9784,8233,7393,80916,44217,17027,7952,7362,6042,5642,1357,7093,1532,4186,8852,7781,7081,5441,2823,5165,5125,3363,4821,6621,102787596502592533353497861893602912260394123146543200108272319193911021104554289154657923529662104132817364341461501601262702054301464192420000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
3
48
45
41
38
35
31
28
25
519
510
520
518
511
499
505
518
502
497
486
469
454
439
427
415
403
388
375
381
367
354
341
328
315
472
483
465
872
660
1,221
1,084
10,079
9,848
9,561
9,281
8,989
8,739
10,963
10,714
14,676
14,154
13,704
13,281
12,829
12,366
11,894
606
5
0
0560611,89412,36612,82913,28113,70414,15414,67610,71410,9638,7398,9899,2819,5619,84810,0791,0841,2216608724654834723153283413543673813753884034154274394544694864975025185054995115185205105192528313538414548330000000000000000000000000000000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
3
48
45
41
38
35
31
28
25
23
22
41
48
50
46
61
83
75
79
77
68
62
56
53
49
46
40
35
50
45
40
36
32
28
193
213
204
619
416
986
1,084
10,079
9,848
9,561
9,281
8,989
8,739
10,963
10,714
14,676
14,154
13,704
13,281
12,829
12,366
11,894
606
5
0
0560611,89412,36612,82913,28113,70414,15414,67610,71410,9638,7398,9899,2819,5619,84810,0791,084986416619204213193283236404550354046495356626877797583614650484122232528313538414548330000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
496
488
479
470
461
453
444
435
427
418
409
401
392
383
374
366
357
348
340
331
322
314
305
296
287
279
270
261
253
244
235
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000023524425326127027928729630531432233134034835736637438339240140941842743544445346147047948849600000000000000000000000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
0
0
0
0
1,353
1,729
6,697
1,417
1,907
2,124
2,789
1,904
2,843
3,864
4,845
3,636
1,260
1,194
2,714
2,533
2,513
3,444
3,365
3,262
3,443
2,858
2,668
2,668
4,143
2,482
2,292
1,755
1,755
1,876
2,263
1,865
2,374
1,588
1,296
1,499
1,774
1,630
1,797
1,782
1,675
1,465
2,428
3,518
4,616
5,308
6,882
6,638
4,959
3,127
3,378
4,025
5,512
18,714
3,320
4,989
4,866
4,465
5,209
4,484
54,198
54,991
42,835
48,044
34,733
21,643
29,820
22,125
131,510
131,681
130,382
141,160
132,736
144,524
132,214
126,623
125,427
126,275
99,225
99,833
96,185
19,890
19,050
20,231
8,355
2,872
2,287
2,2872,8728,35520,23119,05019,89096,18599,83399,225126,275125,427126,623132,214144,524132,736141,160130,382131,681131,51022,12529,82021,64334,73348,04442,83554,99154,1984,4845,2094,4654,8664,9893,32018,7145,5124,0253,3783,1274,9596,6386,8825,3084,6163,5182,4281,4651,6751,7821,7971,6301,7741,4991,2961,5882,3741,8652,2631,8761,7551,7552,2922,4824,1432,6682,6682,8583,4433,2623,3653,4442,5132,5332,7141,1941,2603,6364,8453,8642,8431,9042,7892,1241,9071,4176,6971,7291,3530000
   > Total Current Liabilities 
0
0
0
0
1,353
1,729
6,697
1,417
1,907
2,124
2,789
1,904
2,843
3,864
4,845
3,636
1,260
1,194
2,714
2,533
2,513
3,444
3,365
3,262
3,443
2,858
2,668
2,668
4,143
2,482
2,292
1,755
1,755
1,876
2,263
1,865
2,374
1,588
1,296
1,499
1,774
1,630
1,797
1,782
1,675
1,465
2,428
3,518
4,616
5,308
6,882
6,638
4,959
3,127
3,378
4,025
5,512
17,220
3,320
4,989
4,866
4,465
5,209
4,484
7,885
4,784
10,904
11,851
14,301
10,068
9,929
10,257
23,304
31,486
37,012
33,376
30,294
30,365
30,523
23,956
24,443
23,435
22,653
23,621
20,340
8,564
8,038
9,616
8,355
2,872
2,287
2,2872,8728,3559,6168,0388,56420,34023,62122,65323,43524,44323,95630,52330,36530,29433,37637,01231,48623,30410,2579,92910,06814,30111,85110,9044,7847,8854,4845,2094,4654,8664,9893,32017,2205,5124,0253,3783,1274,9596,6386,8825,3084,6163,5182,4281,4651,6751,7821,7971,6301,7741,4991,2961,5882,3741,8652,2631,8761,7551,7552,2922,4824,1432,6682,6682,8583,4433,2623,3653,4442,5132,5332,7141,1941,2603,6364,8453,8642,8431,9042,7892,1241,9071,4176,6971,7291,3530000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,204
1,746
1,800
1,856
1,914
1,974
1,656
1,742
2,602
2,686
2,770
2,856
2,110
1,015
2,104
0
0
0
0002,1041,0152,1102,8562,7702,6862,6021,7421,6561,9741,9141,8561,8001,7461,2040000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
0
433
453
926
140
192
86
212
253
254
334
278
140
420
187
805
860
1,197
1,226
870
1,066
1,130
713
690
1,112
957
1,270
635
760
529
765
768
698
328
331
381
441
594
533
448
528
537
557
809
700
1,708
1,111
2,152
2,711
863
253
448
466
1,079
749
382
242
585
751
1,089
1,259
3,643
1,555
2,158
1,969
4,787
3,098
3,038
2,492
2,437
6,375
5,555
5,571
6,355
8,472
6,256
8,257
7,918
8,418
4,067
4,389
6,134
3,220
1,378
3,176
3,168
976
596
5969763,1683,1761,3783,2206,1344,3894,0678,4187,9188,2576,2568,4726,3555,5715,5556,3752,4372,4923,0383,0984,7871,9692,1581,5553,6431,2591,0897515852423827491,0794664482538632,7112,1521,1111,7087008095575375284485335944413813313286987687655297606351,2709571,1126907131,1301,0668701,2261,197860805187420140278334254253212861921409264534330000
       Other Current Liabilities 
0
0
0
0
920
1,276
5,771
1,277
1,715
2,038
2,577
1,651
2,589
3,530
4,567
3,496
840
1,007
1,909
1,673
1,316
2,218
2,495
2,196
2,313
2,145
1,978
1,556
3,186
2,873
1,657
1,532
1,226
1,111
1,495
1,167
2,046
1,257
915
1,058
1,180
1,097
1,349
1,254
1,138
908
1,619
2,818
2,908
4,197
4,730
3,927
4,096
2,874
2,930
3,559
4,433
2,428
2,938
3,711
3,285
2,767
3,230
2,382
3,454
2,489
4,766
5,685
4,559
3,295
3,835
5,287
6,090
4,935
10,229
5,962
7,474
5,142
8,778
9,254
9,949
7,915
13,003
14,879
11,033
3,234
5,645
4,336
5,187
1,896
1,691
1,6911,8965,1874,3365,6453,23411,03314,87913,0037,9159,9499,2548,7785,1427,4745,96210,2294,9356,0905,2873,8353,2954,5595,6854,7662,4893,4542,3823,2302,7673,2853,7112,9382,4284,4333,5592,9302,8744,0963,9274,7304,1972,9082,8181,6199081,1381,2541,3491,0971,1801,0589151,2572,0461,1671,4951,1111,2261,5321,6572,8733,1861,5561,9782,1452,3132,1962,4952,2181,3161,6731,9091,0078403,4964,5673,5302,5891,6512,5772,0381,7151,2775,7711,2769200000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,494
0
0
0
0
0
0
46,313
50,207
31,931
36,193
20,432
11,575
19,891
11,868
108,206
100,195
93,370
107,784
102,442
114,159
101,691
102,667
100,984
102,840
76,572
76,212
75,845
11,326
11,012
10,615
0
0
0
00010,61511,01211,32675,84576,21276,572102,840100,984102,667101,691114,159102,442107,78493,370100,195108,20611,86819,89111,57520,43236,19331,93150,20746,3130000001,494000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
108,206
92,123
85,528
100,176
97,051
107,044
106,602
93,456
92,213
90,459
64,545
0
64,545
0
0
0
0
0
0
00000064,545064,54590,45992,21393,456106,602107,04497,051100,17685,52892,123108,206000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
0
5,933
4,838
25,671
24,143
22,942
21,712
20,337
18,597
16,521
14,718
12,940
9,688
9,135
19,764
17,585
15,819
13,777
25,587
23,268
19,936
16,535
24,162
20,638
20,638
15,213
12,805
9,159
7,381
7,381
5,742
3,802
3,346
1,794
3,355
3,926
1,794
4,599
2,725
25,787
23,165
34,872
31,152
58,727
52,525
45,192
37,609
72,856
64,960
59,791
55,941
51,638
46,906
41,652
42,331
54,890
54,902
50,838
43,566
38,358
32,913
50,459
39,759
53,470
37,882
47,930
47,280
77,285
74,498
78,218
82,328
73,498
44,962
41,362
31,827
77,250
67,806
52,413
37,308
48,374
34,354
24,624
81,361
59,488
51,029
33,020
24,878
22,098
22,09824,87833,02051,02959,48881,36124,62434,35448,37437,30852,41367,80677,25031,82741,36244,96273,49882,32878,21874,49877,28547,28047,93037,88253,47039,75950,45932,91338,35843,56650,83854,90254,89042,33141,65246,90651,63855,94159,79164,96072,85637,60945,19252,52558,72731,15234,87223,16525,7872,7254,5991,7943,9263,3551,7943,3463,8025,7427,3817,3819,15912,80515,21320,63820,63824,16216,53519,93623,26825,58713,77715,81917,58519,7649,1359,68812,94014,71816,52118,59720,33721,71222,94224,14325,6714,8385,9330000
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
78,436
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000000000000000000078,4360000000000000000000000000000000000
   Retained Earnings Total Equity0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
31
50
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-56
0
0
0
-86
0
0
0
-78
0
0
0
-45
0
0
0
-49
0
0
0
-94
0
0
-259,000
-62
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000-62-259,00000-94000-49000-45000-78000-86000-5600000000000000000000000000000000000000000050310000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
361,654
364,278
367,055
369,171
371,516
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000371,516369,171367,055364,278361,6540000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
9,058
9,058
34,623
34,636
34,636
34,636
34,636
34,636
34,636
34,636
34,636
34,636
34,636
53,145
53,141
53,098
53,098
68,274
68,266
68,266
68,266
78,145
78,099
78,124
78,124
78,124
80,337
78,124
78,188
78,308
0
79,292
79,382
82,555
84,667
84,804
89,710
90,300
116,116
116,247
131,169
132,345
166,244
167,429
168,637
170,047
214,403
215,437
215,930
216,700
217,498
218,137
218,653
223,602
224,276
224,890
225,169
226,685
227,556
228,059
264,858
268,700
270,387
272,153
279,148
281,492
331,714
333,256
355,452
361,654
364,278
367,055
369,171
371,516
422,705
425,902
426,572
428,091
428,904
430,322
430,621
430,984
420,174
420,842
421,239
421,104
421,001
421,001421,104421,239420,842420,174430,984430,621430,322428,904428,091426,572425,902422,705371,516369,171367,055364,278361,654355,452333,256331,714281,492279,148272,153270,387268,700264,858228,059227,556226,685225,169224,890224,276223,602218,653218,137217,498216,700215,930215,437214,403170,047168,637167,429166,244132,345131,169116,247116,11690,30089,71084,80484,66782,55579,38279,292078,30878,18878,12480,33778,12478,12478,12478,09978,14568,26668,26668,26668,27453,09853,09853,14153,14534,63634,63634,63634,63634,63634,63634,63634,63634,63634,63634,6239,0589,0580000



6.3. Balance Sheets

All numbers in thousands.




6.4. Cash Flows

All numbers in thousands.




6.5. Income Statements

All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-06-30. All numbers in thousands.

Gross Profit (+$)
totalRevenue65,297
Cost of Revenue-383
Gross Profit64,91464,914
 
Operating Income (+$)
Gross Profit64,914
Operating Expense-50,755
Operating Income14,54214,159
 
Operating Expense (+$)
Research Development16,561
Selling General Administrative23,295
Selling And Marketing Expenses2,557
Operating Expense50,75542,413
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income14,542
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)17,77811,306
EBIT - interestExpense = 25,997
25,400
17,778
Interest Expense0
Earnings Before Interest and Taxes (EBIT)25,99717,778
Earnings Before Interest and Taxes (EBITDA)26,380
 
After tax Income (+$)
Income Before Tax17,778
Tax Provision-0
Net Income From Continuing Ops017,778
Net Income17,778
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses50,755
Total Other Income/Expenses Net3,2360
 

Technical Analysis of MEI Pharma Inc.
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of MEI Pharma Inc.. The general trend of MEI Pharma Inc. is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine MEI Pharma Inc.'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. MEI Pharma Inc. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of MEI Pharma Inc..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 2.305 < 2.305 < 2.305.

The bearish price targets are: 1.805 > 1.7974 > 1.7974.

Know someone who trades $0JW9? Share this with them.👇

MEI Pharma Inc. Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of MEI Pharma Inc.. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

MEI Pharma Inc. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of MEI Pharma Inc.. The current macd is -0.13322059.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the MEI Pharma Inc. price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for MEI Pharma Inc.. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the MEI Pharma Inc. price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
MEI Pharma Inc. Daily Moving Average Convergence/Divergence (MACD) ChartMEI Pharma Inc. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of MEI Pharma Inc.. The current adx is 70.21.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy MEI Pharma Inc. shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
MEI Pharma Inc. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of MEI Pharma Inc.. The current sar is 1.7974.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
MEI Pharma Inc. Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of MEI Pharma Inc.. The current rsi is 42.71. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
MEI Pharma Inc. Daily Relative Strength Index (RSI) ChartMEI Pharma Inc. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of MEI Pharma Inc.. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the MEI Pharma Inc. price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
MEI Pharma Inc. Daily Stochastic Oscillator ChartMEI Pharma Inc. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of MEI Pharma Inc.. The current cci is 22.59.

MEI Pharma Inc. Daily Commodity Channel Index (CCI) ChartMEI Pharma Inc. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of MEI Pharma Inc.. The current cmo is 14.03.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
MEI Pharma Inc. Daily Chande Momentum Oscillator (CMO) ChartMEI Pharma Inc. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of MEI Pharma Inc.. The current willr is -48.73194222.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that MEI Pharma Inc. is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
MEI Pharma Inc. Daily Williams %R ChartMEI Pharma Inc. Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of MEI Pharma Inc..

MEI Pharma Inc. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of MEI Pharma Inc.. The current atr is 0.04249509.

MEI Pharma Inc. Daily Average True Range (ATR) ChartMEI Pharma Inc. Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of MEI Pharma Inc.. The current obv is 25,654.

MEI Pharma Inc. Daily On-Balance Volume (OBV) ChartMEI Pharma Inc. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of MEI Pharma Inc.. The current mfi is 12.69.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
MEI Pharma Inc. Daily Money Flow Index (MFI) ChartMEI Pharma Inc. Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for MEI Pharma Inc..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-12-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-10MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-12-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-12-20MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-12-27MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-12-30MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-01-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-01-14WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-01-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-01-17ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-23ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-01-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-02-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-02-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-02-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-26MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-10MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-14BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-08STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-09ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-11ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-14STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-04-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

MEI Pharma Inc. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of MEI Pharma Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.707
Ma 20Greater thanMa 501.944
Ma 50Greater thanMa 1002.291
Ma 100Greater thanMa 2002.467
OpenGreater thanClose2.109
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of MEI Pharma Inc. with someone you think should read this too:
  • Are you bullish or bearish on MEI Pharma Inc.? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about MEI Pharma Inc.? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about MEI Pharma Inc.

I send you an email if I find something interesting about MEI Pharma Inc..


Comments

How you think about this?

Leave a comment

Stay informed about MEI Pharma Inc..

Receive notifications about MEI Pharma Inc. in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.